Discuss as:

What you need to know about the Novartis drug recall

Scott Olson / Getty Images

Four different Novartis products may contain tablets or caplets from other Novartis products packaged at the company’s Lincoln., Neb. facility.

In addition, the FDA warned Monday some of Novartis' over-the-counter pills may have been packaged with prescription opioid drugs sold by Endo Pharmaceuticals, which are packaged at the same facility. Those drugs include Percocet, Endocet, Opana and Zydone.

The FDA says the risk of finding a wrong tablet among the prescription medications is low.

As for the over-the-counter medications, Novartis has voluntarily recalled all bottle sizes of Excedrin and NoDoz with expiration dates of Dec. 20, 2014 or earlier, as well as Bufferin and Gas-X Prevention products with expiration dates of Dec. 20, 2013 or earlier, in the U.S.

Consumers who have purchased these products should return them to Novartis for a full refund.

Contact the Novartis Consumer Relationship Center at 1-888-477-2403 (available Monday-Friday 9 a.m. to 8 p.m. Eastern Time) for information on how to return the affected products and receive reimbursement.

A full list of the recalled products, below, can also be found on the FDA website:


Bufferin  Extra Strength Tablet

Bufferin  Low Dose Tablets

Bufferin  Regular Strength Tablets



Excedrin Back & Body Caplets

Excedrin Extra Strength Caplets

Excedrin Extra Strength Express Gel Caps

Excedrin Extra Strength Gel Tablets

Excedrin Extra Strength Tablets

Excedrin Migraine Express Gel Caplets

Excedrin Migraine Caplets

Excedrin Migraine Gel Tablets

Excedrin Migraine Tablets

Excedrin PM Caplets

Excedrin PM Express Gel Caplet

Excedrin PM Tablets

Excedrin Sinus Headache Caplets

Excedrin Tension Headache Caplets

Excedrin Tension Headache Express Gel Caplets

Excedrin Tension Headache Gel Tablets



Gas-X Prevention Caplets


No Doz

NoDoz Maximum Strength Caplets